Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Bayer bets big as hemophilia competition hots up

12.03.2014 / Scripintelligence

Bayer has announced it is investing €500m in Germany to create new manufacturing capacity for two hemophilia A treatments in its late-stage pipeline. The recombinant Factor VIII products in question are BAY 81-8973 and BAY 94-9027, both of which…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: